Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Authorised
- Spectinomycin sulfate
- Lincomycin hydrochloride
Product identification
Medicine name:
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Linco-Spectin 100, 222/444,7 mg/g κόνις για χορήγηση με πόσιμο νερό για χοίρους και ορνίθια
Active substance:
- Spectinomycin sulfate
- Lincomycin hydrochloride
Target species:
-
Pig
-
Chicken
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Spectinomycin sulfate575.90milligram(s)1.00gram(s)
-
Lincomycin hydrochloride241.90milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for use in drinking water
Withdrawal period by route of administration:
-
Oral use
-
Pig
-
Meat and offalno withdrawal period0 days; Animals must not be slaughtered for human consumption during treatment.
-
-
Chicken
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Package description:
- Linco-Spectin 100 222 mg/g - 444.7 mg/g pwdr. for drinking water 1.5 kg
- Linco-Spectin 100 222 mg/g - 444.7 mg/g pwdr. for drinking water 150 g
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- 7850
Date of authorisation status change:
Reference member state:
-
Belgium
Procedure number:
- BE/V/0029/001
Concerned member states:
-
Austria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 4/04/2025
How useful was this page?: